Literature DB >> 9228091

Carbohydrate binding specificity of the neutrophil-activating protein of Helicobacter pylori.

S Teneberg1, H Miller-Podraza, H C Lampert, D J Evans, D G Evans, D Danielsson, K A Karlsson.   

Abstract

The possible interaction of the neutrophil-activating protein of Helicobacter pylori with target cell glycoconjugates was investigated by the binding of 125I-labeled recombinant protein to glycosphingolipids from human neutrophils in solid phase assays. Thereby, a distinct binding of the neutrophil-activating protein to four bands in the acid glycosphingolipid fraction from human neutrophils was detected, whereas no binding to the non-acid glycosphingolipids or polyglycosyl ceramides from these cells was obtained. When using glycosphingolipids not present in the cell membrane of human neutrophils, it was found that the neutrophil-activating protein also bound to sulfated glycosphingolipids as sulfatide and sulfated gangliotetraosyl ceramide. Comparison of the binding preferences of the protein to reference glycosphingolipids from other sources suggested that in human granulocytes, the neutrophil-activating protein of H. pylori preferentially recognizes glycoconjugates with a terminally unsubstituted NeuAcalpha3Galbeta4GlcNAcbeta3Galbeta4GlcNAcbeta sequence.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9228091     DOI: 10.1074/jbc.272.30.19067

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  Helicobacter pylori SabA adhesin evokes a strong inflammatory response in human neutrophils which is down-regulated by the neutrophil-activating protein.

Authors:  Christoffer Petersson; Maria Forsberg; Marina Aspholm; Farzad O Olfat; Tony Forslund; Thomas Borén; Karl-Eric Magnusson
Journal:  Med Microbiol Immunol       Date:  2006-06-07       Impact factor: 3.402

2.  Galectin-8-N-domain recognition mechanism for sialylated and sulfated glycans.

Authors:  Hiroko Ideo; Tsutomu Matsuzaka; Takamasa Nonaka; Akira Seko; Katsuko Yamashita
Journal:  J Biol Chem       Date:  2011-02-02       Impact factor: 5.157

3.  Helicobacter pylori neutrophil activating protein as target for new drugs against H. pylori inflammation.

Authors:  Theodora Choli-Papadopoulou; Filippos Kottakis; Georgios Papadopoulos; Stefanos Pendas
Journal:  World J Gastroenterol       Date:  2011-06-07       Impact factor: 5.742

4.  Carbohydrate phenotyping of human and animal milk glycoproteins.

Authors:  Anki Gustafsson; Imre Kacskovics; Michael E Breimer; Lennart Hammarström; Jan Holgersson
Journal:  Glycoconj J       Date:  2005-03       Impact factor: 2.916

Review 5.  Structural and functional aspects of the Helicobacter pylori secretome.

Authors:  Giuseppe Zanotti; Laura Cendron
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

6.  Different glycosphingolipid composition in human neutrophil subcellular compartments.

Authors:  A Karlsson; H Miller-Podraza; P Johansson; K A Karlsson; C Dahlgren; S Teneberg
Journal:  Glycoconj J       Date:  2001-03       Impact factor: 2.916

7.  Helicobacter pylori and complex gangliosides.

Authors:  Niamh Roche; Jonas Angström; Marina Hurtig; Thomas Larsson; Thomas Borén; Susann Teneberg
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

Review 8.  Regulation of vacuolar pH and its modulation by some microbial species.

Authors:  Kassidy K Huynh; Sergio Grinstein
Journal:  Microbiol Mol Biol Rev       Date:  2007-09       Impact factor: 11.056

9.  Detection and evaluation of antibodies against neutrophil-activating protein of Helicobacter pylori in patients with gastric cancer.

Authors:  Min Long; Jun Luo; Yan Li; Fang-Yin Zeng; Ming Li
Journal:  World J Gastroenterol       Date:  2009-05-21       Impact factor: 5.742

10.  Sulfatide recognition by colonization factor antigen CS6 from enterotoxigenic Escherichia coli.

Authors:  Lena Jansson; Joshua Tobias; Catharina Jarefjäll; Michael Lebens; Ann-Mari Svennerholm; Susann Teneberg
Journal:  PLoS One       Date:  2009-02-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.